Skip to main content
Earnings Labs
Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (ATRA)

NASDAQ·Healthcare·Biotechnology

$8.38

+0.96%

Mkt Cap $40.81M

Analyst Ratings

Buy

1

Hold

1

Sell

0

Price Target (7 analysts)

$13.00

Range $13.00 – $13.00

Implied Upside

+55.1%

Consensus $13.00 vs current $8.38